Endocrinology and Metabolism in the Elderly

  • Timothy B. Seaton
  • Michael Bergman
  • Wendel S. Price
  • Panayiotis D. Tsitouras
  • Steven R. Gambert
Part of the Contemporary Geriatric Medicine book series (COGM, volume 2)


For years, the endocrine system has been the subject of great interest and controversy for those interested in the aging process and health care of the elderly. In fact, the same individual, Brown-Séquard, has been credited as being the “founder” of both gerontology and endocrinology.


Postmenopausal Woman Thyroid Hormone Sexual Activity Endometrial Cancer Endometrial Carcinoma 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Davidson, M. B., 1979, The effects of aging on carbohydrate Metabolism: A review of the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly, Metabolism 2: 688–705.Google Scholar
  2. 2.
    Kendal, J. M., 1970, The influence on age on the xylose absorption test, Gut 11: 498–501.Google Scholar
  3. 3.
    Seltzer, H. S., 1982, Diagnosis of diabetes, in: Diabetes mellitus, theory and practice, ( M. Ellenberg and H. Rifkin, (eds.) McGraw-Hill, New York, pp. 415–450.Google Scholar
  4. 4.
    DeFronzo R. A., 1979, Glucose intolerance and aging. Evidence for tissue insensitvity to insulin, Diabetes 28: 1095–1011.Google Scholar
  5. 5.
    Wrenshall, G. A., Bogoch, A, and Ritchie, R. C.., 1952, Extractable insulin of pancreas: Correlation with pathological and clinical findings in diabetic and nondiabetic cases, Diabetes 1: 87–107.PubMedGoogle Scholar
  6. 6.
    Duckworth, W. C., and Kitabchi, A. E., 1976, The effect of age on plasma proinsulin-like material after oral glucose, J. Lab. Clin. Med. 88: 359–367.PubMedGoogle Scholar
  7. 7.
    Pagano, G., Cassader, M., Cavallo-Perin, P., Bruno A., Masciola, P., Ozzello, A., Dall’omo, A. M., and Foco, A., 1984, Insulin resistance in the aged: A quantitative evaluation of in vivo insulin sensitivity and in vitro glucose transport, Metabolism 33: 976–981.PubMedGoogle Scholar
  8. 8.
    Lockwood, D. H. and Armaturda, J. M., 1983, Cellular alteration responsible for insulin resistance in obesity and type II diabetes mellitus, Eds Lebowitz, H. E., Reaven, G. M., in New perspective in noninsulin-dependent diabetes mellitus and the role of glipizide in its treatment, Am. J. Med 23–31.Google Scholar
  9. 9.
    Andres, R., 1971, Aging and diabetes, Med. Clin. North. Am. 55: 835–845.PubMedGoogle Scholar
  10. 10.
    Andres, R., 1967, Relation of physiologic changes in aging to medical changes of disease in the aged, Mayo Clin Proc. 42: 674–684.PubMedGoogle Scholar
  11. 11.
    National Diabetes Data Group, 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance, Diabetes 28: 1039–1057.Google Scholar
  12. 12.
    Pirart, J., 1978, Diabetes mellitus and its degenerative complications: A prospective study of 4,400 patients, Diabetes Care 1:168–188, 250–263.Google Scholar
  13. 13.
    Graf, R. J., Halter, J. B., and Porte, D., 1978, Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in men, Diabetes 27: 834–839.PubMedGoogle Scholar
  14. 14.
    Jarrett, R. J. and Keen, H., 1976, Hyperglycemia and diabetes mellitus, Lancet 2: 1009–1012.PubMedGoogle Scholar
  15. 15.
    Whitehouse, F. W., Arky R. A., Bell, D. I., Lawrence, P. A., and Freinkel, N., 1979, The UGDP controversy (policy statement), Diabetes 28: 168–170.Google Scholar
  16. 16.
    Kolterman, O. G., Gray, R. S., Shaprio, G., Scarlett, J. A., Griffin, J., and Olefsky, J. M., 1984, The acute and chronic effects of sulfonylurea therapy in type II diabetic subjects, Diabetes 33: 346–354.PubMedGoogle Scholar
  17. 17.
    Melander, A. and Wahlin-Boll, E., 1983, Clinical pharmokinetics of sulfonylureas: A brief review, Ann. of Clin. Res. 15 (supplement 37) 12–15.Google Scholar
  18. 18.
    Lebovitz, H. E., 1983, Clinical utility of oral hypoglycemic agents in the management of patients with noninsulin dependent diabetes mellitus, Am. J. Med. (Symposium Nov. 30, 1983 ): 94–99.Google Scholar
  19. 19.
    Clark, A. J. L., Knight, G., Wiles, P. G., Keen, H., Ward, J. D., Cauldwell, J. M., Adeniyi-Jones, R. O., Leiper, J. M., Jones, R. H., MacCruish, A. C., Watkins, P. J., Glynne, A., and Scotton, J. B., 1982, Biosynthetic human insulin in the treatment of diabetes. A double blind crossover trial in established diabetic patients, Lancet (2): 354–357.Google Scholar
  20. 20.
    Kahn, C. R. and Rosenthal, A. S., 1979, Immunologic reactions to insulin: Insulin allergy, insulin resistance and the autoimmune insulin syndrome, Diabetes Care 2: 283–295.PubMedGoogle Scholar
  21. 21.
    Watkins, P. J., Choice of insulin, 1983, Br. Med. J. 287: 1571–1572.Google Scholar
  22. 22.
    Brewer, H. B., Jr., 1983, Moderator, Type III Hyperlipoproteinemia: Diagnosis Molecular defects, pathology, and treatment, Ann. Intern. Med. 98: 623–640.PubMedGoogle Scholar
  23. 23.
    Havel, R. J., 1982, Familial dysbetalipoproteinemia, Med. Clin. North Am. 66: 441–454.Google Scholar
  24. 24.
    Durrington, P. N. and Cairns, S. A., 1982, Acute pancreatitis: A complication of beta-blockade, Br. Med. J. 1: 1016.Google Scholar
  25. 25.
    Barr, D. P., Russ, E. M., and Eder, H. A., 1951, Protein-lipid relationships in human plasma. II: In atherosclerosis and related conditions, Am. J. Med. 11: 480–493.PubMedGoogle Scholar
  26. 26.
    Glomset, J. A., 1966, Role of plasma lecithin: Cholesterol acyltransferase in the metabolism of high density lipoproteins, J. Lipid Res. 7: 638–648.PubMedGoogle Scholar
  27. 27.
    Miller, G. J. and Miller, N. E., 1975, Plasma high density lipoprotein concentration and development of ischemic heart disease, Lancet 1: 16–19.PubMedGoogle Scholar
  28. 28.
    Kannel, W. B., Castelli, W. P., and Gordon, T., 1979, Cholesterol in the prediction of atherosclerotic disease, Ann. Intern. Med. 90: 85–91.PubMedGoogle Scholar
  29. 29.
    Gofman, J. W., DeLalla, O., Glazier, F., Freeman, N. K., Lindgren, F. T., Nichols, A. V., Strisower, B., and Tamplin, A. R., 1954, The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease, Plasma 2: 413–484.Google Scholar
  30. 30.
    Eder, H. A., Feder, A., and Gidez, L. I., 1980, Lipoproteins and lipoprotein subclasses in diabetes mellitus, in: Diabetes, 1979, Proceedings of the 10th Congress of the International Diabetes Federation ( W. K. Waldhausl, ed.), Excerpta Medica, Amsterdam, pp. 600–604.Google Scholar
  31. 31.
    U.S. Department of Health and Human Services, 1980, Public Health Service, National Institutes of Health, Lipid Metabolism Branch, NHLBI. The Lipid Research Clinics, Population Studies Data Book, Vol. 1., Bethesda, NIH Publication No. 80: 1527.Google Scholar
  32. 32.
    Nicholson, J., Gartside, P. S., Siegel, M., Spencer, W., Steiner, P. M., and Glueck, C. J., 1979, Lipid and lipoprotein distribution in octo-and nonagenarians, Metabolism 28: 51–55.PubMedGoogle Scholar
  33. 33.
    Noma, A., Matsushita, S., Komori, T., Abe, K., Otabe, H., Kuramoto, K., and Murakami, M., 1979, high and low density lipoprotein cholesterol in myocardial and cerebral infarction, Atherosclerosis 32: 327–331.Google Scholar
  34. 34.
    Gidez, L. J. and Eder, H. A., The clinical significance of plasma high density lipoprotein, in: The Clinical Aspect of High Density Lipoprotein (N. Miller and G. Miller), (in press) Elsevier, Amsterdam.Google Scholar
  35. 35.
    Krauss, R. M., 1982, Regulation of high density lipoprotein levels, in: Lipid Disorders, Med Clinics N. Amer., Vol. 66 ( R. J. Havel, eds.) W. B. Saunders Company, Philadelphia, pp. 403–430.Google Scholar
  36. 36.
    Fredrickson, D. S., 1972, A physician’s guide to hyperlipidemia, Mod. Concepts Cardiovasc. Dis. 4: 31.Google Scholar
  37. 37.
    Miller, N. E., 1984, Why does plasma low density lipoprotein concentration in adults increase with age? Lancet 1: 263–267.PubMedGoogle Scholar
  38. 38.
    Heiss, G., Tamir, I., Davis, C. E., Tyroler, H. A., Rifkind, B. M., Schonfeld, G., Jacobs, D., and Frantz, I. D., Lipoprotein-cholesterol distributions in selected North American Populations: The Lipid Research Clinics Program prevalence study, Circulation 61: 302–315.Google Scholar
  39. 39.
    Keys, A., 1982, The optimum serum cholesterol, Lancet 2: 656.Google Scholar
  40. 40.
    Lipid Research Clinics Program, 1979, The coronary primary prevention trial: Resign and implemention, J. Chronic Dis. 32: 609–631.Google Scholar
  41. 41.
    Connor, W. E. and Connor, S. L., 1982, The dietary treatment of hyperlipidemia, Med. Clin. North Am. 89: 485–518.Google Scholar
  42. 42.
    Ahrens, E. H., Hirsch, J., Ottle, K., Farguhar, J. W., and Stein, Y., 1961, Carbohydrate induced and fat induced lipidemia, Trans. Assoc. Am. Physicians 74: 134–146.PubMedGoogle Scholar
  43. 43.
    Antonis, A. and Behrson, I., 1961, The influence of diet on serum tirglycerides on South African white and Barta prisoners, Lancet 1: 309.Google Scholar
  44. 44.
    Weinsier, R. L., Seeman, A., Herrera, M. G., Assal, J. P., Soeldner, J. S., and Gleason, R. E., 1974, High and low carbohydrate diets in diabetes: Study of effects of diabetic control, insulin secretion and blood lipids, Ann. Intern. Med. 80: 332–345.PubMedGoogle Scholar
  45. 45.
    Brunzell, J. D., Lerner, R. L., Hazzard, W. R., Porte, D., and Bierman, E. L., 1971, Improved glucose tolerance with high carbohydrate feeding in mild diabetics, N. Engl. J. Med. 284: 521–524.PubMedGoogle Scholar
  46. 46.
    Ginsberg, H., Olefsky, J., Farguhar, J. W., and Reaven, G. M., 1974, Moderate ethanol ingestion and plasma triglyceride levels: A study in normal and hypertriglyceridemic persons, Ann. Intern. Med., 80: 143–149.PubMedGoogle Scholar
  47. 47.
    Keys, A., Grande, F., and Auders, J. T., 1961, Fiber and pectin in the diet and serum cholesterol concentration in man, Proc. Soc. Exp. Biol. Med. 106: 555–558.PubMedGoogle Scholar
  48. 48.
    Sidney, S. and Farguhar, F. M., 1983, Cholesterol cancer and public health policy, Am. J. Med. 75: 494–508.PubMedGoogle Scholar
  49. 49.
    Duffield, R. G. M., Muller, N. E., Brunt, J. N. H., Lewis, B., Jamieson, C. W., and Colchester, A. C. F., 1983, Treatment of hyperlipidemia retards progression of symptomatic femoral atherosclerosis, Lancet 2: 639–642.PubMedGoogle Scholar
  50. 50.
    Lipid Research Clinics Program, 1984, The lipid research clinics coronary primary prevention trial results, I. Reduction in incidence of coronary heart disease, JAMA 25: 351–364.Google Scholar
  51. 51.
    Lipid Research Clinics Program, 1984, The lipid clinics coronary primary prevention trial results: II, The Relationship of reduction in incidence of CHD to cholesterol lowering, JAMA, 251: 365–374.Google Scholar
  52. 52.
    Davignon, J., 1981, Diet and drugs in the treatment of hyperlipoproteinemias, in: Hyperlipidemia, Medcom, Inc., New York, pp. 42.Google Scholar
  53. 53.
    Vecchio, T. J., Linden, C. V., O’Connell, M. J., and Heilman, J., 1982, Comparative Efficacy of Colestipol and Clofibrate in type IIa hyperlipoproteinemia, Arch. Intern. Med. 142: 721–723.Google Scholar
  54. 54.
    Nash, D. T., 1983, New agent—Gemfibrozil in the fight against heart disease, Drug Ther. 8: 173–178.Google Scholar
  55. 55.
    Grundy, S. M., 1983, Experience with individual lipid-lowering drugs: Clofibrate, Cardiovascular Review and Report, Symposium on Hyperlipidemias, Le Jecq Publishing, New York, pp. 40–44.Google Scholar
  56. 56.
    Committee of Principal Investigators, 1984, WHO cooperative trial on primary prevention of ischaemic heart disease with Clofibrate to lower serum cholesterol: Final mortality follow-up, Lancet 2: 600–604.Google Scholar
  57. 57.
    Coronary Drug Project Research Group, 1977, Gall bladder disease as a side effect of drugs influencing lipid metabolism, N. Engl. J. Med. 296: 1185–1190.Google Scholar
  58. 58.
    Herbert, P. N., 1983, Experience with individual lowering drugs: Probucol, Cardiovascular Review and Report, Symposium on Hyperlipidemia, Le Jacq Publishing, New York, pp. 38–39.Google Scholar
  59. 59.
    Letorier, J., DuBreuil-Quidoz, S., and Lassier-Cacan, S., 1977, Diet and probucol in lowering cholesterol concentrations: Additive effects on plasma cholesterol concentrations in patients with familial type II hyperlipoproteinemia, Arch. Intern. Med. 137: 1429–1434.Google Scholar
  60. 60.
    Atmeh, R. F., Stewart, J. M., Boag, D. E., Pachard, C. J., Lorimer, A. R., and Shepherd, J., 1983, The hypolipidemic actions of probucol in a study of its effects on high and low density lipoproteins, J. Lipid Res. 24: 588–594.PubMedGoogle Scholar
  61. 61.
    Heel, R. C., Brogden, R. N., Speight, T. M., et al., 1978, Probucol: A review of its pharmacological properties and therapeutic use in patients with hypercholesterolemia, Drugs 15: 409–428.PubMedGoogle Scholar
  62. 62.
    Havel, R. J., 1983, Experience with individual lipid-lowering drugs: Nicotinic Acid, Cardiovascular Review and Reports, Symposium on Hyperlipidemia, Le Jacq Publishing, New York, pp. 48–49.Google Scholar
  63. 63.
    Grundy, S. M., Ahrens, E. H., and Dargnon, J., 1969, The interation of cholesterol absorption and cholesterol synthesis in man, J. Lipid Res. 10: 304.PubMedGoogle Scholar
  64. 64.
    Schlierf, G., Oster, P., Henck, C. C. Raetzer, H., and Schellenberg, B., 1978, Sitosterol in juvenile type II hyperlipoproteinemia, Atherosclerosis 30: 245–248.Google Scholar
  65. 65.
    Schulman, R. S., Bhattacharyya, A. K., Connor, W. E., and Frederickson, D. S. 1976, B Satosterolemia and xanthomatosis, N. Engl. J. Med. 294: 482 - 483.Google Scholar
  66. 66.
    Ehnholm, C., Huttunen, J. K., Kununer, P. J., Miettinen, T. A., and Nikkila, E. A. 1975, Effect of oxandrolone treatment on the activity of lipoprotein lipuse, hepatic lipase and phospholipid, A, of human post-heparin plasma, N. Engl. J. Med. 292: 1314–1317.PubMedGoogle Scholar
  67. 67.
    Tobert, J. A., Bell, G. D., Birtwell, J., et al., 1982, Cholesterol-lowering effect of mevinolin, an inhibitor of 3 hydroxy-3-methylglutaryl-coenzyme A reductase in healthy volunteers, J. Clin. Invest. 69: 913–919.PubMedGoogle Scholar
  68. 68.
    Illingworth, R. D., 1984, Mevinolin plus colestipol in therapy for severe heterozygous famililar hypercholesterolemia, Ann. Intern. Med. 101: 598–604.PubMedGoogle Scholar
  69. 69.
    Kane, J. P., Mallon, M. J., Tun, P., Phillips, N. R., Freedman, D. D., Williams, M. L., Rowe, J. S., and Havel, R. J., 1981, Normalization of low density lipoprotein levels in heterozygous familial hypercholesterolemia with combined drug regimen, N. Engl. J. Med. 304: 251–258.PubMedGoogle Scholar
  70. 70.
    Tzankoff, S. P. and Norris, A. H., 1976, Effect of muscle mass decrease in agerelated BMR changes, J. Appl. Physiol. 43: 1001–1006.Google Scholar
  71. 71.
    Denckla, W. D., 1974, Role of the pituitary and thyroid glands on the decline of minimal O2 consumption with age, J. Clin. Invest. 53: 572–581.PubMedGoogle Scholar
  72. 72.
    Ingbar, S., 1978, The influence of aging on human thyroid economy, in: Geriatric Endocrinology ( R. B. Greenblatt ed.), Raven Press, New York.Google Scholar
  73. 73.
    Braverman, L., Dawber, N., and Ingbar, S., 1966, Observations concerning the binding of thyroid hormone in the sera of normal subjects of varying ages, J. Clin. Invest. 45: 1273–1279.PubMedGoogle Scholar
  74. 74.
    Hesch, R. D, Gatz, J., and Pope, J., 1976, Total and free triiodothyronine and thyroid-binding globulin concentration in elderly human persons, Eur. J. Clin. Invest. 6: 139–145.PubMedGoogle Scholar
  75. 75.
    Davis, P. and Davis, F., 1974, Hyperthyroidism in patients over the age of 60 years, Medicine 53: 161–181.PubMedGoogle Scholar
  76. 76.
    Hermann, J., Rusche, H. J., Kroll, H. J., Hilger, P., and Kruskemper, H. L., 1974, Free triiodothyronine (T3) and thyroxine (T4) serum levels in old age, Horm. Metabl. Res. 6: 239–240.Google Scholar
  77. 77.
    Wenzel, K. W. and Horn, W. R., June, 1975, Triiodothyronine (T3) and thyroxine (T4) kinetics in aged men. Program, 7th International Thyroid Conference, Boston, Excerpta Medica, ICS #361, Abstract No. 154.Google Scholar
  78. 78.
    Chopra, I. J. and Smith, S. R., 1975, Circulating thyroide hormones and thyrotropin in adult patients with protein-calorie malnutrition, J. Clin. Endocrinol. Metab. 40: 221–227.PubMedGoogle Scholar
  79. 79.
    Mashang, Jr. T., Parks, J. S., Baker, L., Vaidya, V., Utiger, R. D., Bongiovanni, A. M., and Snyder, P. J., 1975, Low serum triiodothyronine in patients with anoroxia nervosa, J. Clin. Endocrinol. Metab. 40: 470–473.Google Scholar
  80. 80.
    Chopra, I. J., Chopra, U., Smith, S. R., Reza, M., and Solomon, D., 1975, Reciprocal changes in serum concentrations of 3,3′,5′-triiodothyronine (reverse T3) and 3,3′,5-triiodothyronine (T3) in systemic illnesses, J. Clin. Endocrinol. Metab. 41: 1043–1049.PubMedGoogle Scholar
  81. 81.
    Bermudez, F., Surks, M. I., and Oppenheimer, J. H., 1975, High incidence of decreased serum triiodothyronine concentration in patients with nonthyroidal disease, J. Clin. Endocrinol. Metab. 41: 27–40.PubMedGoogle Scholar
  82. 82.
    Bermudez, F., Surks, M., and Oppenheimer, J., 1975, High incidence of decreased serum T3 concentration in patients with nonthyroidal disease, J. Clin. Endocrinol. Metab. 41: 27–40.PubMedGoogle Scholar
  83. 83.
    Burrows, A. W., Cooper, E., Shakespear, R. A., Aickin, C. M., Hesch, R. D., and Burke, C. W., 1977, Low serum T3 levels in the elderly sick: Protein binding, thyroid and pituitary responsiveness and reverse T3 concentrations, Clin. Endocrinol. 7: 289–292.Google Scholar
  84. 84.
    Vagenakis, A. G., Burger, A., Portnay, G. I., Rudolph, M., O’Brien, J. T., Azizi, F., Arky, R. A., Nicod, P., Ingbar, S. H., and Braverman, L. E., 1975, Diversion of peripheral thyroxine metabolism from activating to inactivating pathways during complete fasting. J. Clin. Endocrinol. Metab. 41: 191–194, 1975.PubMedGoogle Scholar
  85. 85.
    Balsam, A. and Ingbar, S. H., 1978, The influence of fasting, diabetes, and several pharmacological agents in the pathways of thyroxine metabolism in rat liver, J. Clin. Invest. 63: 415–424.Google Scholar
  86. 86.
    Azizi, F., Vagenakis, G. I., Portnay, B., Rapoport, B., and Ingbar, S. H., and Braverman, L. E., 1975, Pituitary-thyroid responsiveness to intramuscular thyrotropinreleasing hormone based on analyses of serum thyroxcine, triiodothyronine and thyrotropin concentrations, N. Engl. J. Med. 292: 273–276.PubMedGoogle Scholar
  87. 87.
    Guttelod, S., Lemarchand-Beraud, T., Magnenat, P., Perret, C., Poli, S. and Venotti, A., 1974, Effect of age and role of kidneys and liver on thyrotropin turnover in man, Metabolism, 23: 101–113.Google Scholar
  88. 88.
    Lemarchand-Beraud, T. H. and Vanotti, A., 1969, Relationships between blood thyrotropin levels, protein bound iodine and free thyroxine concentration in man under normal physiological conditions, Acta Endocrinol (Kbh) 60: 315–317.Google Scholar
  89. 89.
    Ohara, H., Kobayaski, T., Shiraishi, M., and Wada, T., 1974, Thyroid function of the aged as viewed from the pituitary-thyroid system. Endocrinol. Jpn. 21: 377–381.PubMedGoogle Scholar
  90. 90.
    Sawin, C. T., Chopra, D., Azizi, F., Mannix, J. E., and Bacharach, P., 1979, The aging thyroid: Increased prevalence of elevated serum thyrotropin levels in the elderly, J. Am. Med. Soc. 242: 247–250.Google Scholar
  91. 91.
    Snyder, P. and Utiger, R., 1972, Response to TRH in normal man, J. Clin. Endocrinol. Metab. 34: 380–385.PubMedGoogle Scholar
  92. 92.
    Snyder, P. J. and Utiger, R. D., 1972, Thyrotropin respone to thyrotropin releasing hormone in normal females over forty, J. Clin. Endocrinol. Metab. 34: 1096–1101.PubMedGoogle Scholar
  93. 93.
    Wenzel, K. W., Meinhold, H., Herpich, M., Adlkofer, F., and Schleusener, H., 1974, TRH-stimulationstest mit alters-und geschlechsabhangigem TSH-antieg bein normalpersonen, Klin. Wochenschr. 52: 721–724.Google Scholar
  94. 94.
    Campbell, A. J., Reinken, J., and Allan, B. C., 1981, Thyroid disease in the elderly community, Age Aging 10: 47–52, 1981.Google Scholar
  95. 95.
    Gambert, S. R., Garthwaite, T. L., Pontzer, C. H., and Hagen, T. C., 1980, Agerelated changes in central nervous system beta-endorphin and ACTH, Neuroendocrinology 31: 252–255.PubMedGoogle Scholar
  96. 96.
    Gambert, S. R., 1981, Interaction of age and thyroid hormone status on beta-endorphin content in rat corpus striatum and hypothalamus, Neuroendocrinology 32: 114–117.PubMedGoogle Scholar
  97. 97.
    Lahey, F. H., 1931, Non-activated (apathetic) type of hyperthyroidism, N. Engl. J. Med. 204: 747–748.Google Scholar
  98. 98.
    Gambert, S. R., Ingbar, S. H., and Hagen, T. C., 1980, Interaction of age and thyroid hormone status on Na+ K+ ATPase in rat renal cortex and liver, Endocrinology 108: 27–30.Google Scholar
  99. 99.
    Jeffreys, P., 1972, The prevalence of thyroid disease in patients admitted to a geriatric department, Age Aging 1: 33–37.Google Scholar
  100. 100.
    Bahemuka, M. and Hodkinson, H., 1957, Screening for hypothyroidism in elderly patients, Br. Med. J. 2: 601–605.Google Scholar
  101. 101.
    Ahronheim, J. and Libow, L., 1981, High occurrence rate of hypothyroidism in a frail elderly population. Proceedings of the 34th Annual Meeting of the Gerontological Society of American, Toronto, Canada, Abstract No. 162.Google Scholar
  102. 102.
    Ingbar, S. H. and Braverman, L. E., 1975, Active form of the thyroid hormone, Ann. Rev. Med. 26: 443–447.PubMedGoogle Scholar
  103. 103.
    Kaplan, M. M., Larsen, P. R., Crantz, F. R., Dzau, V. J., and Rossing, T. H., 1982, Prevalence of abnormal thyroid function test results in patients wtih acute medical illnesses, Am. J. Med. 72: 9–16.PubMedGoogle Scholar
  104. 104.
    Rosenbaum, R. L. and Barzel, U. S., 1982, Levothyroxine replacement dose for primary hypothyroidism decreases with age, Ann. Intern. Med. 96: 53–55.PubMedGoogle Scholar
  105. 105.
    Davis, E. B., Lamantia, R. S., Sapulding, S. W., and Davis, P. J., 1980, Conventional therapy overtreats elderly hypothyroid patients. Proceedings of the 62nd Annual Meeting of the Endocrine Society, Annaheim, California, Abstract No. 33.Google Scholar
  106. 106.
    Gregerman, R. I., Gaffney, G. W., and Shock, N. W., 1962, Thyrosine turnover in euthyroid man with special reference to changes with age, J. Clin. Invest. 41: 2065–2074.PubMedGoogle Scholar
  107. 107.
    Murad, F. and Haynes, Jr., R. C., 1980, Androgens and anabolic steroids, in: The Pharmacological Basis of Therapeutics ( A. Goodman Gilman, L. S. Goodman, and A. Gilman, eds.), MacMillan Publishing Co., New York, p. 1448.Google Scholar
  108. 108.
    Masters, W. H. and Johnson, V. E., 1966, Human Sexual Response, Little, Brown and Co., Boston, pp. 248–270.Google Scholar
  109. 109.
    Kinsey, A. C., Pomeroy, W. B., and Martin, C. E., 1948, Sexual Behavior in the Human Male, W. B. Saunders Company, Philadelphia.Google Scholar
  110. 110.
    Martin, C. E., 1977, Sexual activity in the aging male, in: Handbook of Sexology ( J. Money and H. Mousafh, eds.), Elsevier, Amsterdam, pp. 313–824.Google Scholar
  111. 111.
    Harman, S. M., 1978, Clinical aspects of aging of the male reproductive system, in: The Aging Reproductive System, Aging, Vol. 4 ( E. L. Schneider, ed.), Raven Press, New York, pp. 29–58.Google Scholar
  112. 112.
    Karacan, I., Williams, R. L., Thronby, J. I., and Salis, P. J., 1975, Sleep related penile tumescence as a function of age, Am. J. Psychiatry 132: 932–937.PubMedGoogle Scholar
  113. 113.
    Johnson, J., 1975, Impotence, Br. J. Psychiatry 9: 206–211.Google Scholar
  114. 114.
    Tsitouras, P. D., Martin, C. E., and Harman, S. M., 1982, Relationship of serum testosterone to sexual activity in healthy elderly men, J. Gerontol. 37 (3): 288–293.PubMedGoogle Scholar
  115. 115.
    Gregerman, R. I. and Bierman, E. L., 1981, Aging and hormones, in: Textbook of Endorincology ( R. H. Williams, ed.), W. B. Saunders Company, Philadelphia, pp. 1192–1212.Google Scholar
  116. 116.
    Bardin, C. W. and Paulsen, C. A., 1981, The testes, in: Textbook of Endocrinology ( R. H. Williams, ed.), W. B. Saunders Company, Philadelphia, pp. 293–354.Google Scholar
  117. 117.
    Eik-Nes, K. B., 1975, Biosynthesis and secretion of testicular steroids, in: Handbook of Physiology, Section 7: Endocrinology, Vol. V: Male Reproductive System ( D. W. Hamilton and R. O. Greep, eds.), Williams and E. Wilkins, Baltimore, pp. 95–116.Google Scholar
  118. 118.
    Kastin, A. J. and Schally, A. V., 1972, Release of LH and FSH after administration of synthetic LHRH, J. Clin. Endocrinol. Metab. 34: 753–757.PubMedGoogle Scholar
  119. 119.
    Reichlin, S., 1981. Neuroendocrinology, in: Textbook of Endocrinology ( R. H. Williams, ed.), W. B. Saunders Company, Philadelphia, pp. 588–644.Google Scholar
  120. 120.
    Vermeulen, A., Rubens, R., and Verdonck, L., 1972, Testosterone section and metabolism in male senescence, J. Clin. Endocrinol. Metab 34: 730–735.PubMedGoogle Scholar
  121. 121.
    Stearns, E. L,. MacDonald, J. A., Kaufman, B. J., Lucman, T. S., Winter, J.S., and Faiman, C., 1974, Declining testicular function with age, hormonal and clinical correlates, Am. J. Med. 57 (5): 761–766.Google Scholar
  122. 122.
    Baker, H. W. G., Brenner, W. J., Burger, H. G., DeKretser, D. M., Dulmans, A., Eddie, L. W., Hudson, B., Keogh, E. J., Lee, V. W. K., and Rennie, G. C., 1976, Testicular control of follicle stimulating hormone secretion, Recent Prog. Horm. Res. 32: 429–476.Google Scholar
  123. 123.
    Pirke, K. M. and Doerr, P., 1973, Age related changes and interrelationships between plasma testosterone, estradiol, and testosterone binding globulin in normal adult males, Acta Endocrinol (Kbh) 74: 729–800.Google Scholar
  124. 124.
    Horton, R., Hsieh, P., Barberia, J., Pages, L., and Cosgrove, M., 1975, Altered blood androgens in elderly men with prostate hyperplasia, J. Clin. Endocrinol. Metab. 41 (4): 793–796.PubMedGoogle Scholar
  125. 125.
    Vermeulen, A. and Verdonck, L., 1972, Some studies on the biological significance of free testosterone, J. Steroid. Biochem. 3: 421–426.PubMedGoogle Scholar
  126. 126.
    Kley, H. K., Nieschlag, E., Bidlingmaier, F., and Kriiskemper, H. L., 1974, Possible age-dependent influence of estrogens on the binding of testosterone in plasma of adult men, Horm. Metab. Res. 6: 213–216.Google Scholar
  127. 127.
    Pirke, K. M. and Doerr, P., 1975, Age related changes in free plasma testosterone, dihydrotestosterone, and estradiol, Acta. Endocrinol (Kbh) 80 (1): 171–178.Google Scholar
  128. 128.
    Rubens, R. M., Dhout, M., and Vermeulen, A., 1974, Further studies on Leydig cell function in old age, J. Clin. Endocrinol. Metab. 39: 40–45.PubMedGoogle Scholar
  129. 129.
    Hemsell, D. L., Grodin, J. M., Brenner, P. F., Siiteri, P. K., and McDonald, P. C., 1974, Plasma precursors of estrogen. II: Correlation of the extent of conversion of plasma androstenedione to estrone with age, J. Clin. Endocrinol. Metab. 38: 476–479.PubMedGoogle Scholar
  130. 130.
    Greenblatt, R. B., Oettinger, M., and Bohler, C. S. S., 1976, Estrogen-androgen levels in aging men and women, therapeutic considerations, J. Am. Geriatr. Soc. 24: 173–178.PubMedGoogle Scholar
  131. 131.
    Longcope, C., 1973, The effect of human chorionic gonadotrophin on plasma steroid levels in young and old men, Stenods 21: 583–592.Google Scholar
  132. 132.
    Mazzi, C., Riva, L. R., and Bernasconi, D., 1974, Gonadotrophins and plasma testosterone in senescence, in: The Endocrine Function of the Human Testis (V. H. T. James, M. Serio, and L. Martin, eds.), Academic Press, New York, Vol. 2, pp. 51–62.Google Scholar
  133. 133.
    Tillenger, L. G., Birke, G., Franksson, C., and Plantin, L. O., 1955, The steroid production of the testicles and the relation to the number and morphology of Leydig cells, Acta. Endocrinol. (Kbh.) 19: 340–348.Google Scholar
  134. 134.
    Kaler, L. W. and Neaves, W. B., 1978, Attrition of the human Leydig cell population with advancing age, Anat. Rec. 192 (4): 513–518.Google Scholar
  135. 135.
    Harman, S. M. and Tsitouras, P. D., 1980, Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin, J. Clin. Endocrinol. Metab. 51: 35–40.PubMedGoogle Scholar
  136. 136.
    Harman, S. M. and Tsitouras, P. D., 1982, Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone, J. Clin. Endocrinol. Metab. 54: 547–551.PubMedGoogle Scholar
  137. 137.
    Brenner, W. J. and Prinz, P. N., 1981, The diumal rhythm in testosterone levels is lost with aging in normal men, 63rd Annual Meeting of the Endocrine Society, Abstract #480.Google Scholar
  138. 138.
    Sparrow, D., Bosse, R., and Rowe, J. W., 1980, The influence of age, alcohol consumption and body build on gonadal function in men, J. Clin. Endocrinol. Metab. 51: 508–512.PubMedGoogle Scholar
  139. 139.
    Pazzagli, M., Forti, G., Capellini, A., and Serio, M., 1975, Radioimmunoassay of plasma dihydrotestosterone in normal and hypogonadal men, Clin. Endocrinol. (Oxf.) 4: 513–520.Google Scholar
  140. 140.
    Giusti, G., Gonelli, P., Borreli, D., Fiorelli, G., Forti, G., Pazzagli, M., and Serio, M., 1975, Age-related secretion of androstenedione, testosterone, and dihydrotestosterone by the human testis, Exp. Gerontol. 10 (5): 241–245.Google Scholar
  141. 141.
    Pirke, K. M. and Doerr, P., 1975, Plasma dihydrotestosterone in normal adult males and its relation to testosterone, Acta. Endocrinol. (Kbh.) 79: 357–365.Google Scholar
  142. 142.
    Sawin, C. T., Chopra, D., Azizi, F., Mannix, J. E., and Bacharach, P., 1979, The aging thyroid. Increased prevalence of elevated serum thyrotropin levels in the elderly, JAMA 242 (3): 247–250.PubMedGoogle Scholar
  143. 143.
    Muta, K., Kato, K., Akamine, Y., and Ibayishi, H., 1981, Age related changes in the feedback regulation of gonadotropin secretion by sex steroids in men, Acta Endocrinol. ( Kbh. ) 96: 154–162.Google Scholar
  144. 144.
    Snyder, P. J., Reitano, J. F., and Utiger, R. D., 1975, Serum LH and FSH repsonses to synthetic gonadotropin releasing hormone in normal men, J. Clin. Endocrinol. Metab. 41 (5): 938–945.PubMedGoogle Scholar
  145. 145.
    Hang, E. A., Aakvaag, A., Sand, T., and Torjesen, P. A., 1974, The gonadotrophin response to synthetic GnRH in males in relation to age, dose, and basal serum levels of estradiol-17-β and gonadotrophins, Acta. Endocrinol. (Kbh.) 77 (4): 625–635.Google Scholar
  146. 146.
    Harman, S. M., Tsitouras, P. D., Costa, P. T., Loriaux, D. L., and Sherins, R. J., 1982, Evaluation of pituitary gonadotropic function in men: Value of luteinizing hormone-releasing hormone response versus basal luteinizing hormone level for discrimination of diagnosis, J. Clin. Endocrinol. Metab. 54: 196–200.PubMedGoogle Scholar
  147. 147.
    Gordon, G. G., Altman, K., Southern, A. L., Rubin, E., and Lieber, C. S., 1976, Effects of alcohol on sex-hormone metabolism in normal men, N. Engl. J. Med. 295: 793–797.PubMedGoogle Scholar
  148. 148.
    Turner, T. B., Mezey, E., and Kimball, A. W., 1977, Measurement of alcoholrelated effects in man: Chronic effects in relation to level of alcohol consumption, Johns Hopkins Med. J. 141: 235–248.PubMedGoogle Scholar
  149. 149.
    Michael, R. P. and Zympe, D., 1978, Potency in male rhesus monkeys: Effect of continuously receptive females, Science 200: 451–453.PubMedGoogle Scholar
  150. 150.
    Martin, C. E,, 1981, Factors affecting sexual functioning in 60–79 year old married males, Arch. Sex. Behav. 5: 399–420.Google Scholar
  151. 151.
    Kent, J. Z. and Acone, A. B., 1966, Plasma androgens and aging, in: Androgens in Normal and Pathological Conditions (A. Vermeulen and D. Exley, eds.), Excerpta Medica FOundation ICS #101, Amsterdam, pp. 31–40.Google Scholar
  152. 152.
    Wesson, M. B., 1964, The value of testosterone in men past middle age, J. Am. Geriatr. Soc. 12: 1149–1153.PubMedGoogle Scholar
  153. 153.
    Reiter, T., 1963, Testosterone implantation: A clinical study of 240 implantations in aging males, J. Am. Geriatr. Soc. 11: 540–550.PubMedGoogle Scholar
  154. 154.
    Vaughn, T. C. and Hammond, C. B., 1981, Estrogen replacement therapy, Clin. ObsteL Gynecol. 24 (1): 253–283.Google Scholar
  155. 155.
    Notelovitz, M., 1978, Gynecologic problems of menopausal women. I. Changes in genital tissue, Geriatrics 33 (8): 24–30.PubMedGoogle Scholar
  156. 156.
    Quigley, M. M. and Hammond, C. B., 1979, Estrogen-replacement therapy: Help or hazzard ? N. Engl. J. Med. 301: 646–648.PubMedGoogle Scholar
  157. 157.
    Jaffe, R. B., 1978, The menopause and perimenopausal period, in: Reproductive Endocrinology: Physiology, Pathophysiology, and Clinical Management ( S. S. G. Yen and R. B. Jaffe, eds.), W. B. Saunders Company, Philadelphia.Google Scholar
  158. 158.
    Jaszmann, L. J. B., 1976, Epidemiology of the climacteric syndrome, in: The Management of the Menopause and post-menopausal years ( S. Campbell, ed.), University Park Press, Baltimore.Google Scholar
  159. 159.
    Gregerman, R. I. and Bierman, E. L., 1981, Aging and hormones, in: Textbook of Endocrinology ( R. H. Williams, ed.), W. B. Saunders Company, Philadelphia, pp. 1192–1209.Google Scholar
  160. 160.
    Sherman, B. M. and Korenman, S. G., 1975, Hormonal characteristics of the human menstrual cycle throughout reproductive life, J. Clin. Invest, 55: 699–706.PubMedGoogle Scholar
  161. 161.
    Sherman, B. M., West, J. H., and Korenman, S. J., 1976, The menopausal transition: analysis of LH, FSH, estrodiol, and progesterone concentrations during menstrual cycles of older women, J. Clin. Endocrinol. Metab., 42: 629–636.PubMedGoogle Scholar
  162. 162.
    Muta, K., Kato, K., Akamine, Y., and Ibayishi, H., 1981, Age related changes in the feedback regulation of gonadotropin secretion by sex steroids in men, Acta Endocrinol. (Kbh.), 96: 154–162.Google Scholar
  163. 163.
    Geola, F. L., Frimar, A. M., Tataryn, I. V., Lu, K. H., Hershman, J. M., Eggena, P., Sambhi, M. P., and Judd, H. L., 1980, Biological effects of various doses of equine conjugated estrogens in postmenopausal women, J. Clin. Endocrinol. Metab., 51: 620–625.PubMedGoogle Scholar
  164. 164.
    Yen, S. S. C., Tsai, C. C., Naftolin, F., Vandenburg, G., and Ajabor, L., 1972, Pulsatile patterns of gonadotropoin release in subjects with and without ovarian function, J. Clin. Endocrinol. Metab. 34: 671–675.PubMedGoogle Scholar
  165. 165.
    Silver, T. M. and Yen, S. S. C., 1973, Augmented gonadotropin response to synthetic LRF in hypogonadal state, J. Clin. Endocrinol. Metab. 37: 491–494.Google Scholar
  166. 166.
    Vermeulen, A., Rubens, R., and Verdonck, L., 1972, Testosterone secretion and metabolism in male senescence, J. Clin. Endocrinol. Metab. 34: 730–735.PubMedGoogle Scholar
  167. 167.
    Harman, S. M. and Tsitouras, P. D., 1980, Reproductive hormones in aging men. I. Measurement of sex steroids, basal LH and Leydig cell response to hCG, J. Clin. Endocrinol. Metab., 51: 35–40.Google Scholar
  168. 168.
    Hutton, J. D., Jacobs, H. S., and James, V. H. T., 1979, Steroid endocrinology after the menopause: A review, J. Roy. Soc. Med., 1979 (11): 835–841.Google Scholar
  169. 169.
    Judd, H. L., 1976, Hormonal dynamics associated with the menopause, Clin. Obstet. Gynecol., 19: 775–788.Google Scholar
  170. 170.
    Judd, H. L., 1980, Reproductive hormone metabolism in postmenopausal women, in: Menopause, Comprehensive Management ( B. A. Eskin, ed.), Masson Publishing Co., New York, 55–71.Google Scholar
  171. 171.
    Aksel, S., Schömberg, D. W., Tyrey, L., and Hammond, C. B., 1976, Vasomotor symptoms, serum estrogens and gonadotropin levels in surgical menopause, Am. J. Obstet. Gynecol. 126: 165–169.PubMedGoogle Scholar
  172. 172.
    Grodin, J. M., Siiteri, P. K., and MacDonald, B. C., 1973, Source of estrogen production in postmenopausal women, J. Clin. Endocrinol. Metab. 36: 207–214.PubMedGoogle Scholar
  173. 173.
    Elahi, D., Muler, D., Tzankoff, S., Andres, R., and Tobin, J. D., 1978, Effect of age and obesity on fasting levels of glucose, insulin, glucagon, and GH, Gerontologist, 18 (part 2): 68 (Abstract).Google Scholar
  174. 174.
    Thompson, J. and Oswald, I., 1977, Effect of estrogen on the sleep, mood and anxiety of menopausal women, Br. Med. J. 2: 1317–1319.Google Scholar
  175. 175.
    Yen, S. S. C., 1977, The biology of menopause, J. Reprod. Med. 18: 287–296.PubMedGoogle Scholar
  176. 176.
    Aitken, J. M., Davidson, A., and England, P., 1974, The relationship between menopausal vasomotor symptoms and gonadotropin excretion in urine after oophorectomy, J. Obstet. Gynaecol. Br. Commonw. 81: 150–154.PubMedGoogle Scholar
  177. 177.
    Meldrum, D. R., Erlik, Y., Lu, J. K. H, and Judd, H. L., 1981, Objectively recorded hot flushes in patients with pituitary insufficiency, J. Clin. Endocrinol. Metab. 52: 684–689.PubMedGoogle Scholar
  178. 178.
    Meldrum, D. R., Tataryn, I. V., Frumar, A. M., Erlik, Y., Lu, K. H., and Judd, H., 1980, Gonadotropins, estrogens and adrenal steroids during the menopausal hot flash, J. Chn. Endocrinol. Metab. 50: 685–689.Google Scholar
  179. 179.
    Casper, R. F., Yen, S. S. C., and Wilkes, M. M., 1979, Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion, Science 205: 823–825.PubMedGoogle Scholar
  180. 180.
    Albrecht, B. H., Schiff, I., Tulchinsky, D., and Ryan, K. J., 1981, Objective evidence that placebo and oral medroxyprogesterone acetate therapy diminish menopausal vasomotor flashes, Am. J. Obstet. Gynecol. 139: 631–635.PubMedGoogle Scholar
  181. 181.
    Clayden, J. R., Bell, J. W., and Pollard, P., 1974, Menopausal flushing: Doublebind trial of a non-hormonal medication, Br. Med. J. 1: 409–412.PubMedGoogle Scholar
  182. 182.
    Worley, R. J., 1981, Age, estrogen and bone density, Clin. Obstet. Gynecol. 24 (1): 203–218.Google Scholar
  183. 183.
    Johnson, R. E. and Specht, E. E., 1981, The risk of hip fracture in postmenopausal females with and without estrogen drug exposure, Am. J. Public Health, 71: 138–144.PubMedGoogle Scholar
  184. 184.
    Christiansen, C., Christensen, M. S., and Transbol, I., 1981, Bone mass in post-menopausal women after withdrawal of estrogen-gestagen replacement therapy, Lancet 1: 459–461.PubMedGoogle Scholar
  185. 185.
    Nordin, B. E. C., Horsman, A., Crilly, R. J., Marshall, D. H., and Simpson, M., 1980, Treatment of spinalosteoporosis in postmenopausal women, Br. Med. J. 2: 451–454.Google Scholar
  186. 186.
    Riggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R., and O’Fallon, W. M., 1982, Effect of fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis, N. Engl. J. Med. 306: 446–450.PubMedGoogle Scholar
  187. 187.
    Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., and Beckman, E. M., 1979, Estrogen replacement therapy: I. A 10-year prospective study in the relationship to osteoporosis, Obstet. Gynecol. 53: 277–281.Google Scholar
  188. 188.
    Masters, W. H. and Johnson, V. E., 1970, Human Sexual Inadequacy, Little, Brown and Co., Boston.Google Scholar
  189. 189.
    Maoz, B. and Durst, N., 1980, The effects of estrogen therapy on the sex life of postmenopausal women, Maturitas 2: 327–336.PubMedGoogle Scholar
  190. 190.
    Deutsch, S., Ossowski, R., and Benjamin, I., 1981, Comparison between degree of systemic absorption of vaginally and orally administered estrogens at different dose levels in postmenopausal women, Am. J. Obstet. Gynecol. 139: 967–968.PubMedGoogle Scholar
  191. 191.
    Schiff, I., Tulchinsky, D., Ryan, K. J., Kadner, S., and Levitz, M., 1980, Plasma estriol and its conjugates following oral and vaginal administration of estriol to postmenopausal women: Correlations wtih gonadotropin levels, Am. J. Obstet. Gynecol. 138: 1137–1141.PubMedGoogle Scholar
  192. 192.
    Keller, T. J., Riedmann, R., and Fischer, M., 1980, Ostron-Ostradiol-und Ostriolgehart nach intravaginaler Applikation von Ostriol in der Postmenopause, Gynaek. Rundsch. 20 (Suppl. l): 77–79.Google Scholar
  193. 193.
    Oliver, M. F., 1976, The menopause and coronary heart disease, in: The Management of the Menopause and Postmenopausal Years ( S. Campbell, ed.), University Park Press, Baltimore.Google Scholar
  194. 194.
    Ryan, K. J., 1976, Estrogen and atherosclerosis, Clin. Obstet. Gynecol. 19: 805–815.Google Scholar
  195. 195.
    Nachtigall, L. E., Nachtigall, R. H., Nachtigall, R. D., and Beckman, E. M., 1979, Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma, cardiovascular and metabolic problems, Obstet. Gynecol. 54: 74–79.Google Scholar
  196. 196.
    Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T. and Chapman, J. M., 1978, Coronary risk and estrogen use in postmenopausal women, Am. J. Epidemiol. 107: 479–487.PubMedGoogle Scholar
  197. 197.
    Hammond, C. B., Jelovsek, F. R., Lee, K. L., Greasman, W. T., and Parker, R. T., 1979, Effects of long-term estrogen replacement therapy: I. Metabolic effects, Am. J. Obstet. Gynecol. 133: 525–536.PubMedGoogle Scholar
  198. 198.
    Cordon, T., Kannel, W. B., Hjortland, M. C., and McNamara, P. M., 1978, Menopause and coronary heart disease. The Framingham study, Ann. Intern. Med. 89: 157–161.Google Scholar
  199. 199.
    Coronary Drug Project Research Group, 1973, J.A.M.A. 226: 652.Google Scholar
  200. 200.
    Tikkanen, M. J., Kuusi, T., Vartiainen, E., and Nikkila, E. A., 1979, Treatment of post-menopausal hypercholesterolemia with estradiol, Acta Obstet. Gynecol. Scand., Suppl. 88: 83–88.Google Scholar
  201. 201.
    Varma, T. R., 1980, Effect of estrogen on fasting serum cholesterol and triglyceride levels in post-menopausal women, Int. J. Gyneacol. Obstet. 17: 551–555.Google Scholar
  202. 202.
    Largelius, A., Johnson, P., Lunell, N.-O., and Samsioe, G., 1981, Treatment with oral estrone sulfate in the female climacteric. I. Influence on Lipids, Acta Obstet. Gynecol. Scand. 60: 27–31.Google Scholar
  203. 203.
    Silfverstolpe, G., Gustafson, A., Samsioe, G., and Svanborg, A., 1979, Lipid metabolic studies in oophorectomized women, Acta Obstet. Gyneacol. Suppl. 88: 89–95.Google Scholar
  204. 204.
    Krauss, R. M., Lindgren, F. T., Wingerd, J., Bradley, D. D., and Ramcharan,S., 1979, Effects of estrogens and progestins on high density lipoproteins, Lipids 14: 114–118.Google Scholar
  205. 205.
    Lillienberg, L., Adlercreutz, H., and Svanborg, A., 1979, Effect of a sequential estrogen-progestin therapy on the plasma level of estrogens and lipids in post-menopausal women, Acta Endocrinol. (Kbh.) 92: 319–329.Google Scholar
  206. 206.
    Paterson, M. E. L., Sturdee, D. W., Moore, B., and Whitehead, T. P., 1980, The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentration in post-menopausal women, Br. J. Obstet. Gynaecol. 87: 552–560.PubMedGoogle Scholar
  207. 207.
    Hirvonen, E., Malkomen, M., and Manninen, D., 1981, Effects of different progestogens on lipoproteins during post-menopausal replacement therapy, N. Engl. J. Med. 304: 560–563.PubMedGoogle Scholar
  208. 208.
    Bland, K. I., Buchanan, J. B., Weisberg, B. F., Hagan, T., and Grey, L. A., 1980, The effects of exogenous estrogen replacement therapy of the breast: Breast cancer risk and mammographic parenchymal patterns, Cancer 45: 3027–3033.PubMedGoogle Scholar
  209. 209.
    Gambrell, R. D., Massey, F. M., Castaneda, T. A., and Boddie, A., 1980, Estrogen therapy and breast cancer in postmenopausal women, J. Am. Geriatr. Soc. 28: 251–257.PubMedGoogle Scholar
  210. 210.
    Ziel, H. K. and Finkle, W. D., 1975, Increased risk of endometrial carcinoma among users of conjugated estrogens, N. Engl. J. Med. 293: 1167–1170.PubMedGoogle Scholar
  211. 211.
    Smith, D. C., Prentice, R., Thompson, D. J., and Hermann, W. L., 1975, Association of exogenous estrogen and endometrial carcinoma, N. Engl. J. Med. 293: 1164–1166.PubMedGoogle Scholar
  212. 212.
    McDonald, T. W., Annegers, J. F., O’Fallon, W. M., Dockerty, M. B., Malkasian, G. D., and Kurlan, L. T., 1977, Exogenous estrogen and endometrial carcinoma. Case-control and incidence study, Am. J. Obstet. Gynecol. 127: 572–580.PubMedGoogle Scholar
  213. 213.
    Weiss, N. S., Szekely, D. R., and Austin, D. F., 1976, Increasing incidence of endo-metrial cancer in the United States, N. Engl. J. Med. 294: 1259–1262.PubMedGoogle Scholar
  214. 214.
    Gardner, W. V., 1944, Tumors in experimental animals receiving steroid hormones, Surgery 6: 8–32.Google Scholar
  215. 215.
    Perry, I. H. and Ginzton, L. L., 1937, Development of tumors in female mice treated with 1,2,5,6-dibenzanthracene and theelin, Am. J. Cancer 29: 680–704.Google Scholar
  216. 216.
    Cook, J. W. and Dodds, E. C., 1933, Sex hormones and cancer producing compounds, Nature (Lond.) 131: 205–206.Google Scholar
  217. 217.
    Mack, T. M., 1978, Exogenous estrogens and endometrial carcinoma: Studies, Criticisms and Current Status, Intern. Symposium on Endometrial Cancer (M. G. Brush, R. J. King, and R. Taylor, eds), Bailliere Tindall, London, pp. 17–28.Google Scholar
  218. 218.
    Klopper, A., 1980, The risk of endometrial carcinoma from estrogen therapy of the menopause, Acta Endocrinol. (Kbh.) Suppl 233: 29–35.Google Scholar
  219. 219.
    Salini, T., 1980, Endometrial carcinoma risk factors with special reference to the use of estrogens, Acta Endocrinol. (Kbh.) Suppl 233: 37–43.Google Scholar
  220. 220.
    Volker, W., Kannengiesser, U., Majewski, A. and Vasterling, H. W., 1978, Ostrogentherapie und Endometriumkarzinom, Geburtschilfe Frauenheilkd 38: 735–743.Google Scholar
  221. 221.
    Hulka, B. S., Kaufman, D. G., Fowler, W. C., Grimson, R. C., and Greenberg, B. G., 1980, Predominance of early endometrial cancers after long-term estrogen use, JAMA 244: 2419–2422.PubMedGoogle Scholar
  222. 222.
    Paterson, M. E. L., Wade-Evans, T., Sturder, D. W., Thorn, M. H., and Studd, J. W. W., 1980, Endometrial disease after treatment with estrogens and progestogens in the climacteric, Br. Med. J. 1: 822–824.Google Scholar
  223. 223.
    King, R. J. B., Whitehead, M. I., Campbell, S., and Minardi, J., 1979, Effect of estrogen and progestin treatments on endometria from postmenopausal women, Cancer Res. 39: 1094–1101.PubMedGoogle Scholar
  224. 224.
    Gambrell, R. D., Massey, F. M., and Castameda, T. A., 1979, Reduced incidence of endometrial cancer among postmenopausal women treated with progestogens, J. Am. Geriatr. Soc. 27: 389–394.PubMedGoogle Scholar
  225. 225.
    Thorn, M. H., White, P. J., Williams, R. M., Sturdee, D. W., Paterson, M. E. L., Wade-Evans, T., and Studd, J. W. W., 1979, Prevention and treatment of endometrial diseaes in climacteric women receiving estrogen therapy, Lancet 2: 455–457.Google Scholar
  226. 226.
    Aiman, J., 1981, Age, estrogen, and the endometrium, Clin Obstet. Gynecol. 24: 192–202.Google Scholar
  227. 227.
    Studd, J. W. W., Thorn, M., Dische, F., Driver, M., Wade-Evans, T., and Williams, D., 1979, Value of cytology for detecting endometrial abnormalities in climacteric women receiving hormone replacement therapy, Br. Med. J. 1: 846–848.PubMedGoogle Scholar
  228. 228.
    Estrogen use and Postmenopausal women, 1979, Ann. Intern. Med. 91: 921–922.Google Scholar
  229. 229.
    Estrogen use and Postmenopausal women, 1979, National Institutes of Health Consensus Development Conference, Vol. 2, No. 8, NIH, Bethesda, MD. 20205.Google Scholar
  230. 230.
    Harman, S. M. and Tsitouras, P. D., 1982, Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin, J. Clin. Endocrinol. Metab. 51: 35–40.Google Scholar
  231. 231.
    Tsitouras, P., Martins, C., and Harman, S. M., 1982, Relationship of serum testosterone to sexual activity in healthy elderly men, J. Gerontol. 37: 288–293.PubMedGoogle Scholar
  232. 232.
    Harman, S. M. and Tsitouras, P. D., 1982, Reproductive hormones in aging men. II. Basal pituitary gonadotropins and gonadotropin responses to luteinizing hormone-releasing hormone, J. Clin. Endocrinol. Metab. 54: 547–551.PubMedGoogle Scholar
  233. 233.
    Tsitouras, P. D., Martin, C. E., and Harman, S. M., 1982, Relationship of serum testosterone to sexual activity in healthy elderly men, J. Gerontol. 37: 288–293.PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1986

Authors and Affiliations

  • Timothy B. Seaton
    • 1
    • 2
  • Michael Bergman
    • 1
    • 2
  • Wendel S. Price
    • 3
  • Panayiotis D. Tsitouras
    • 4
    • 5
  • Steven R. Gambert
    • 6
    • 2
    • 7
  1. 1.Rachmiel Levine Diabetes Center, Department of MedicineNew York Medical CollegeValhallaUSA
  2. 2.Westchester County Medical CenterValhallaUSA
  3. 3.Department of MedicineNew York Medical CollegeValhallaUSA
  4. 4.Coler Memorial HospitalNew YorkUSA
  5. 5.Center for Aging and Adult DevelopmentNew York Medical CollegeValhallaUSA
  6. 6.Division of Gerontology and Geriatric Medicine, Department of Medicine, and Center for Aging and Adult DevelopmentNew York Medical CollegeValhallaUSA
  7. 7.Ruth Taylor Geriatric and Rehabilitation InstituteValhallaUSA

Personalised recommendations